Detailing Maekyung Report on MBK's Tender Offer to Osstem Implant Shareholders at a 20% Premium

377 Views25 Jan 2023 06:54
This post details the Maekyung Report, which came out late yesterday, on MBK's potential tender offer to Osstem Implant shareholders at a 20% premium for a 15% stake.
Sanghyun has highlighted this Insight as a Top Pick
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
(Paid Plans Only)
Top 5%
Sanghyun Park
Korea / Special Sits, Pairs, Index Rebalancing
Clepsydra Capital
South KoreaEvent-DrivenEquity Bottom-Up